Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thoma Cressey Equity Partners was a prominent private equity firm that specialized in the "buy-and-build" investment strategy across several industries, with a significant focus on healthcare services and life sciences. Founded by industry veterans Carl Thoma and Bryan Cressey, the firm sought to consolidate fragmented industries by acquiring platform companies and executing strategic add-on acquisitions. In the healthcare sector, their portfolio included providers, medical products, and healthcare IT companies. In 2008, the firm's partners decided to pursue separate paths, leading to the formation of Thoma Bravo, which focuses on software and technology, and Cressey & Company, which continues to focus exclusively on the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thoma Cressey Funds.